Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 33.48 -9.51% -3.52
ESPR closed down 9.51 percent on Tuesday, August 11, 2020, on 2.89 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ESPR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -9.51%
Down 3 Days in a Row Weakness -9.51%
Down 4 Days in a Row Weakness -9.51%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Biopharmaceutical Diabetes Obesity Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Lipids Low Density Lipoprotein Lipoproteins Atherosclerosis

Is ESPR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 76.98
52 Week Low 24.82
Average Volume 668,185
200-Day Moving Average 46.94
50-Day Moving Average 44.78
20-Day Moving Average 41.54
10-Day Moving Average 38.23
Average True Range 2.44
ADX 30.42
+DI 10.71
-DI 35.99
Chandelier Exit (Long, 3 ATRs ) 45.07
Chandelier Exit (Short, 3 ATRs ) 39.96
Upper Bollinger Band 50.16
Lower Bollinger Band 32.92
Percent B (%b) 0.03
BandWidth 41.49
MACD Line -2.75
MACD Signal Line -2.13
MACD Histogram -0.6239
Fundamentals Value
Market Cap 757.85 Million
Num Shares 22.6 Million
EPS -5.77
Price-to-Earnings (P/E) Ratio -5.80
Price-to-Sales 0.00
Price-to-Book 6.37
PEG Ratio -4.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.84
Resistance 3 (R3) 39.15 37.67 37.94
Resistance 2 (R2) 37.67 36.31 37.52 37.64
Resistance 1 (R1) 35.58 35.47 34.84 35.27 37.35
Pivot Point 34.10 34.10 33.74 33.95 34.10
Support 1 (S1) 32.01 32.74 31.27 31.70 29.61
Support 2 (S2) 30.53 31.90 30.38 29.32
Support 3 (S3) 28.44 30.53 29.02
Support 4 (S4) 28.13